Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
15 abstracts from its cystic fibrosis (CF) research and development
program will be presented at the 28 th Annual North American
Cystic Fibrosis Conference (NACFC) in Atlanta, October 9 to 11, 2014.
for Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 investment picks